Literature DB >> 31334753

S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges.

Nikolaos G Frangogiannis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31334753      PMCID： PMC6703152          DOI： 10.1093/eurheartj/ehz524

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  15 in total

1.  The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2.

Authors:  Claus Kerkhoff; Wolfgang Nacken; Malgorzata Benedyk; Marie Claire Dagher; Claudia Sopalla; Jacques Doussiere
Journal:  FASEB J       Date:  2005-01-10       Impact factor: 5.191

2.  S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.

Authors:  H Christian Volz; Danai Laohachewin; Cathrin Seidel; Felix Lasitschka; Kirsten Keilbach; Alexandra R Wienbrandt; Joachim Andrassy; Angelika Bierhaus; Ziya Kaya; Hugo A Katus; Martin Andrassy
Journal:  Basic Res Cardiol       Date:  2012-02-10       Impact factor: 17.165

3.  Induction of nuclear factor-κB responses by the S100A9 protein is Toll-like receptor-4-dependent.

Authors:  Matteo Riva; Eva Källberg; Per Björk; Dora Hancz; Thomas Vogl; Johannes Roth; Fredrik Ivars; Tomas Leanderson
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

4.  The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells.

Authors:  Matthew J Robinson; Philippe Tessier; Richard Poulsom; Nancy Hogg
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

5.  Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients.

Authors:  Takashi Katashima; Takahiko Naruko; Fumio Terasaki; Masatoshi Fujita; Kaoru Otsuka; Shougo Murakami; Akira Sato; Michiaki Hiroe; Yoshihiro Ikura; Makiko Ueda; Masaki Ikemoto; Yasushi Kitaura
Journal:  Circ J       Date:  2010-02-27       Impact factor: 2.993

6.  MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes.

Authors:  Thomas Vogl; Stephan Ludwig; Matthias Goebeler; Anke Strey; Irmgard S Thorey; Rudolf Reichelt; Dirk Foell; Volker Gerke; Marie P Manitz; Wolfgang Nacken; Sabine Werner; Clemens Sorg; Johannes Roth
Journal:  Blood       Date:  2004-08-26       Impact factor: 22.113

Review 7.  The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.

Authors:  Jan M Ehrchen; Cord Sunderkötter; Dirk Foell; Thomas Vogl; Johannes Roth
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

8.  S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.

Authors:  John H Boyd; Bernard Kan; Haley Roberts; Yingjin Wang; Keith R Walley
Journal:  Circ Res       Date:  2008-04-10       Impact factor: 17.367

Review 9.  The inflammatory response in myocardial injury, repair, and remodelling.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

10.  RAGE signaling sustains inflammation and promotes tumor development.

Authors:  Christoffer Gebhardt; Astrid Riehl; Moritz Durchdewald; Julia Németh; Gerhard Fürstenberger; Karin Müller-Decker; Alexander Enk; Bernd Arnold; Angelika Bierhaus; Peter P Nawroth; Jochen Hess; Peter Angel
Journal:  J Exp Med       Date:  2008-01-21       Impact factor: 14.307
View more
  7 in total

1.  Polymorphisms of Calgranulin Genes and Ischemic Stroke in a Chinese Population.

Authors:  Linfa Chen; Xinglan Chen; Yajun Wang; Shengnan Li; Shaoting Huang; Zhaochun Wu; Jiawen He; Shaofeng Chen; Fu Deng; Peiyi Zhu; Wangtao Zhong; Bin Zhao; Guoda Ma; You Li
Journal:  J Inflamm Res       Date:  2022-06-09

2.  S100A8 and S100A9 are elevated in chronically threatened ischemic limb muscle and induce ischemic mitochondrial pathology in mice.

Authors:  Zachary R Salyers; Vinicius Mariani; Nicholas Balestrieri; Ravi A Kumar; Nicholas A Vugman; Trace Thome; Katelyn R Villani; Scott A Berceli; Salvatore T Scali; Georgios Vasilakos; Terence E Ryan
Journal:  JVS Vasc Sci       Date:  2022-04-21

3.  S100A9 is a functional effector of infarct wall thinning after myocardial infarction.

Authors:  Upendra Chalise; Mediha Becirovic-Agic; Michael J Daseke; Shelby R Konfrst; Jocelyn R Rodriguez-Paar; Dan Feng; Jeffrey D Salomon; Daniel R Anderson; Leah M Cook; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-12-10       Impact factor: 5.125

Review 4.  CARD9 Regulation and its Role in Cardiovascular Diseases.

Authors:  Haina Zhang; Yeling Wang; Hongbo Men; Wenqian Zhou; Shanshan Zhou; Quan Liu; Lu Cai
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

5.  Identification of Potential Biomarkers Associated with Acute Myocardial Infarction by Weighted Gene Coexpression Network Analysis.

Authors:  Yan Wang; Xiangyang Zhang; Min Duan; Chenguang Zhang; Ke Wang; Lili Feng; Linlin Song; Sheng Wu; Xuyan Chen
Journal:  Oxid Med Cell Longev       Date:  2021-08-27       Impact factor: 6.543

6.  C/EBPδ-induced epigenetic changes control the dynamic gene transcription of S100a8 and S100a9.

Authors:  Saskia-Larissa Jauch-Speer; Marisol Herrera-Rivero; Nadine Ludwig; Bruna Caroline Véras De Carvalho; Leonie Martens; Jonas Wolf; Achmet Imam Chasan; Anika Witten; Birgit Markus; Bernhard Schieffer; Thomas Vogl; Jan Rossaint; Monika Stoll; Johannes Roth; Olesja Fehler
Journal:  Elife       Date:  2022-05-11       Impact factor: 8.713

Review 7.  S100 Soil Sensor Receptors and Molecular Targeting Therapy Against Them in Cancer Metastasis.

Authors:  Nahoko Tomonobu; Rie Kinoshita; Masakiyo Sakaguchi
Journal:  Transl Oncol       Date:  2020-03-17       Impact factor: 4.243
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.